All findings presented here are based on survey self-report and should be interpreted in that context.
Real confusion
Notably, the metabolic benefits of dual GLP-1R/GcgR agonists have also been documented in obese non-human primates, where chronic administration of a lower dose of a GLP-1R/GcgR co-agonist vs a GLP-1R mono-agonist reduced body weight and improved glucose tolerance to a greater degree [77]
Similarly, in a cross-sectional study by Johnson et al., analysis of 3-day food records in individuals using GLP-1 RA for at least one month showed that 75% of participants reported having increased their protein intake after treatment, yet only 43% achieved the recommended intake of 1.2 g/kg/day
If approved for a compounded GLP-1 program, follow the prescribing clinician's and dispensing pharmacy's dosing instructions precisely, and contact your clinical provider if you have any questions before administering a dose
or a viral, bacterial, or parasitic infection in your digestive tract